VENUS REMEDIES
|
VENUS REMEDIES Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹601 Cr | ₹556 Cr | ₹600 Cr | ₹548 Cr | ₹339 Cr |
Sales | ₹591 Cr | ₹552 Cr | ₹598 Cr | ₹538 Cr | ₹333 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹10 Cr | ₹3.07 Cr | ₹2.20 Cr | ₹10 Cr | ₹5.93 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹601 Cr | ₹556 Cr | ₹600 Cr | ₹548 Cr | ₹339 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-2.66 Cr | ₹8.04 Cr | ₹3.48 Cr | ₹-7.15 Cr | ₹5.86 Cr |
Raw Material Consumed | ₹357 Cr | ₹323 Cr | ₹384 Cr | ₹348 Cr | ₹168 Cr |
Opening Raw Materials | ₹78 Cr | ₹75 Cr | ₹66 Cr | ₹86 Cr | ₹81 Cr |
Purchases Raw Materials | ₹342 Cr | ₹320 Cr | ₹388 Cr | ₹328 Cr | ₹174 Cr |
Closing Raw Materials | ₹75 Cr | ₹78 Cr | ₹75 Cr | ₹66 Cr | ₹86 Cr |
Other Direct Purchases / Brought in cost | ₹13 Cr | ₹5.16 Cr | ₹4.44 Cr | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹6.35 Cr | ₹5.52 Cr | ₹4.71 Cr | ₹4.58 Cr | ₹4.73 Cr |
Electricity & Power | ₹6.35 Cr | ₹5.52 Cr | ₹4.71 Cr | ₹4.58 Cr | ₹4.73 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹67 Cr | ₹57 Cr | ₹52 Cr | ₹46 Cr | ₹46 Cr |
Salaries, Wages & Bonus | ₹58 Cr | ₹50 Cr | ₹46 Cr | ₹40 Cr | ₹41 Cr |
Contributions to EPF & Pension Funds | ₹4.21 Cr | ₹3.92 Cr | ₹3.67 Cr | ₹3.75 Cr | ₹4.10 Cr |
Workmen and Staff Welfare Expenses | ₹4.31 Cr | ₹3.39 Cr | ₹2.76 Cr | ₹1.77 Cr | ₹0.80 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹29 Cr | ₹32 Cr | ₹32 Cr | ₹23 Cr | ₹21 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹1.88 Cr | ₹2.19 Cr | ₹2.40 Cr | ₹1.80 Cr | ₹1.25 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹27 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr | ₹20 Cr |
General and Administration Expenses | ₹24 Cr | ₹21 Cr | ₹17 Cr | ₹16 Cr | ₹18 Cr |
Rent , Rates & Taxes | ₹1.33 Cr | ₹0.87 Cr | ₹0.83 Cr | ₹0.53 Cr | ₹0.76 Cr |
Insurance | ₹0.75 Cr | ₹0.77 Cr | ₹0.64 Cr | ₹0.52 Cr | ₹0.59 Cr |
Printing and stationery | ₹0.46 Cr | ₹0.38 Cr | ₹0.31 Cr | ₹0.22 Cr | ₹0.23 Cr |
Professional and legal fees | ₹1.13 Cr | ₹0.99 Cr | ₹0.60 Cr | ₹1.18 Cr | ₹1.39 Cr |
Traveling and conveyance | ₹7.59 Cr | ₹6.22 Cr | ₹4.72 Cr | ₹3.34 Cr | ₹5.95 Cr |
Other Administration | ₹12 Cr | ₹11 Cr | ₹9.57 Cr | ₹11 Cr | ₹8.66 Cr |
Selling and Distribution Expenses | ₹61 Cr | ₹49 Cr | ₹46 Cr | ₹64 Cr | ₹35 Cr |
Advertisement & Sales Promotion | ₹13 Cr | ₹8.48 Cr | ₹4.43 Cr | ₹2.58 Cr | ₹6.76 Cr |
Sales Commissions & Incentives | ₹2.17 Cr | ₹4.20 Cr | ₹3.68 Cr | ₹3.15 Cr | ₹2.20 Cr |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹46 Cr | ₹36 Cr | ₹38 Cr | ₹58 Cr | ₹26 Cr |
Miscellaneous Expenses | ₹0.31 Cr | ₹0.26 Cr | - | - | - |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.31 Cr | ₹0.26 Cr | - | - | - |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹542 Cr | ₹495 Cr | ₹538 Cr | ₹494 Cr | ₹299 Cr |
Operating Profit (Excl OI) | ₹60 Cr | ₹60 Cr | ₹62 Cr | ₹54 Cr | ₹41 Cr |
Other Income | ₹12 Cr | ₹10 Cr | ₹8.31 Cr | ₹20 Cr | ₹5.31 Cr |
Interest Received | ₹4.17 Cr | ₹1.90 Cr | ₹0.82 Cr | ₹0.12 Cr | ₹0.33 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹5.95 Cr | ₹7.32 Cr | ₹6.42 Cr | ₹6.50 Cr | ₹2.60 Cr |
Others | ₹1.46 Cr | ₹1.10 Cr | ₹1.08 Cr | ₹13 Cr | ₹2.37 Cr |
Operating Profit | ₹71 Cr | ₹70 Cr | ₹70 Cr | ₹73 Cr | ₹46 Cr |
Interest | ₹0.09 Cr | ₹0.12 Cr | ₹0.48 Cr | ₹13 Cr | ₹13 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | ₹0.18 Cr | ₹6.01 Cr | ₹1.68 Cr |
Other Interest | ₹0.09 Cr | ₹0.12 Cr | ₹0.30 Cr | ₹7.01 Cr | ₹12 Cr |
PBDT | ₹71 Cr | ₹70 Cr | ₹70 Cr | ₹60 Cr | ₹33 Cr |
Depreciation | ₹26 Cr | ₹32 Cr | ₹34 Cr | ₹35 Cr | ₹32 Cr |
Profit Before Taxation & Exceptional Items | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹25 Cr | ₹0.78 Cr |
Exceptional Income / Expenses | - | - | - | ₹23 Cr | ₹-8.81 Cr |
Profit Before Tax | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹49 Cr | ₹-8.04 Cr |
Provision for Tax | ₹16 Cr | ₹11 Cr | ₹-4.32 Cr | ₹-13 Cr | ₹1.96 Cr |
Current Income Tax | ₹12 Cr | - | - | - | - |
Deferred Tax | ₹3.93 Cr | ₹11 Cr | ₹-4.32 Cr | ₹-13 Cr | ₹1.96 Cr |
Other taxes | ₹0.48 Cr | - | - | - | - |
Profit After Tax | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr | ₹-10.00 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr | ₹-10.00 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹142 Cr | ₹116 Cr | ₹75 Cr | ₹13 Cr | ₹24 Cr |
Appropriations | ₹171 Cr | ₹143 Cr | ₹116 Cr | ₹75 Cr | ₹14 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹0.19 Cr | ₹0.46 Cr | ₹-0.24 Cr | ₹0.10 Cr | ₹0.47 Cr |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 | ₹-8.10 |
Adjusted EPS | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 | ₹-8.10 |
Compare Income Statement of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹398.2 Cr | 0.9% | -7.7% | -19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 0.9% |
-7.7% |
-19.9% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses